Trials / Completed
CompletedNCT00234923
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients
A Pilot, Open-Label, Randomized, Comparative Study of the Antiviral Efficacy of Lopinavir/Ritonavir Single-Drug Regimen Versus Lopinavir/Ritonavir in Combination With Lamivudine/Zidovudine in Antiretroviral Naïve Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to obtain a preliminary assessment of the antiviral activity and tolerability of Kaletra single agent therapy as initial treatment for HIV infection, relative to a Kaletra three drug standard of care reference arm
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lopinavir/ritonavir | 400 mg lopinavir/ 100 mg ritonavir, BID |
| DRUG | lamivudine/zidovudine | 300mg lamivudine/150mg zidovudine, BID |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2007-02-01
- First posted
- 2005-10-10
- Last updated
- 2008-04-03
Source: ClinicalTrials.gov record NCT00234923. Inclusion in this directory is not an endorsement.